Serum galectin-3 level as a marker of thrombogenicity in atrial fibrillation


Kocyigit D. , Gurses K. M. , Yalcin M. U. , CANPINAR H. , CANPOLAT U. , EVRANOS B. , ...More

JOURNAL OF CLINICAL LABORATORY ANALYSIS, vol.31, no.6, 2017 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 31 Issue: 6
  • Publication Date: 2017
  • Doi Number: 10.1002/jcla.22120
  • Title of Journal : JOURNAL OF CLINICAL LABORATORY ANALYSIS
  • Keywords: atrial fibrillation, galectin-3, left atrial appendage flow velocity, transesophageal echocardiography, C-REACTIVE PROTEIN, SPONTANEOUS ECHOCARDIOGRAPHIC CONTRAST, PLATELET ACTIVATION, PROTHROMBOTIC STATE, STROKE PREVENTION, RISK-FACTOR, SPAF-III, THROMBOEMBOLISM, ASSOCIATION, QUANTIFICATION

Abstract

BackgroundLeft atrial appendage flow velocity (LAAFV) and presence of spontaneous echo contrast (SEC) have been reported to be predictors of thromboembolism in atrial fibrillation (AF) patients. Galectin-3 is a biomarker reflecting pro-inflammatory status, whose role in AF has recently drawn attention, particularly in persistent AF population.